Schmaljohn A - Search Results

1

Generation of Marburg virus-like particles by co-expression of glycoprotein and matrix protein.

Swenson DL, Warfield KL, Kuehl K, Larsen T, Hevey MC, Schmaljohn A, Bavari S, Aman MJ. Swenson DL, et al. Among authors: schmaljohn a. FEMS Immunol Med Microbiol. 2004 Jan 15;40(1):27-31. doi: 10.1016/S0928-8244(03)00273-6. FEMS Immunol Med Microbiol. 2004. PMID: 14734183 Free article.

2

Marburg virus-like particles protect guinea pigs from lethal Marburg virus infection.

Warfield KL, Swenson DL, Negley DL, Schmaljohn AL, Aman MJ, Bavari S. Warfield KL, et al. Vaccine. 2004 Sep 3;22(25-26):3495-502. doi: 10.1016/j.vaccine.2004.01.063. Vaccine. 2004. PMID: 15308377

3

Lipid raft microdomains: a gateway for compartmentalized trafficking of Ebola and Marburg viruses.

Bavari S, Bosio CM, Wiegand E, Ruthel G, Will AB, Geisbert TW, Hevey M, Schmaljohn C, Schmaljohn A, Aman MJ. Bavari S, et al. Among authors: schmaljohn a, schmaljohn c. J Exp Med. 2002 Mar 4;195(5):593-602. doi: 10.1084/jem.20011500. J Exp Med. 2002. PMID: 11877482 Free PMC article.

4

Ebola virus-like particles protect from lethal Ebola virus infection.

Warfield KL, Bosio CM, Welcher BC, Deal EM, Mohamadzadeh M, Schmaljohn A, Aman MJ, Bavari S. Warfield KL, et al. Among authors: schmaljohn a. Proc Natl Acad Sci U S A. 2003 Dec 23;100(26):15889-94. doi: 10.1073/pnas.2237038100. Epub 2003 Dec 12. Proc Natl Acad Sci U S A. 2003. PMID: 14673108 Free PMC article.

5

Virus-like particles exhibit potential as a pan-filovirus vaccine for both Ebola and Marburg viral infections.

Swenson DL, Warfield KL, Negley DL, Schmaljohn A, Aman MJ, Bavari S. Swenson DL, et al. Among authors: schmaljohn a. Vaccine. 2005 Apr 27;23(23):3033-42. doi: 10.1016/j.vaccine.2004.11.070. Vaccine. 2005. PMID: 15811650

6

Activation of triggering receptor expressed on myeloid cells-1 on human neutrophils by marburg and ebola viruses.

Mohamadzadeh M, Coberley SS, Olinger GG, Kalina WV, Ruthel G, Fuller CL, Swenson DL, Pratt WD, Kuhns DB, Schmaljohn AL. Mohamadzadeh M, et al. Among authors: schmaljohn al. J Virol. 2006 Jul;80(14):7235-44. doi: 10.1128/JVI.00543-06. J Virol. 2006. PMID: 16809329 Free PMC article.

7

Genomic differences between guinea pig lethal and nonlethal Marburg virus variants.

Lofts LL, Ibrahim MS, Negley DL, Hevey MC, Schmaljohn AL. Lofts LL, et al. Among authors: schmaljohn al. J Infect Dis. 2007 Nov 15;196 Suppl 2:S305-12. doi: 10.1086/520585. J Infect Dis. 2007. PMID: 17940965

8

Molecular mechanisms of filovirus cellular trafficking.

Aman MJ, Bosio CM, Panchal RG, Burnett JC, Schmaljohn A, Bavari S. Aman MJ, et al. Among authors: schmaljohn a. Microbes Infect. 2003 Jun;5(7):639-49. doi: 10.1016/s1286-4579(03)00095-9. Microbes Infect. 2003. PMID: 12787740 Free article. Review.

9

Comparison of individual and combination DNA vaccines for B. anthracis, Ebola virus, Marburg virus and Venezuelan equine encephalitis virus.

Riemenschneider J, Garrison A, Geisbert J, Jahrling P, Hevey M, Negley D, Schmaljohn A, Lee J, Hart MK, Vanderzanden L, Custer D, Bray M, Ruff A, Ivins B, Bassett A, Rossi C, Schmaljohn C. Riemenschneider J, et al. Among authors: schmaljohn a, schmaljohn c. Vaccine. 2003 Sep 8;21(25-26):4071-80. doi: 10.1016/s0264-410x(03)00362-1. Vaccine. 2003. PMID: 12922144

10

Characterization of monoclonal antibodies to Marburg virus (strain Musoke) glycoprotein and identification of two protective epitopes.

Hevey M, Negley D, Schmaljohn A. Hevey M, et al. Among authors: schmaljohn a. Virology. 2003 Sep 15;314(1):350-7. doi: 10.1016/s0042-6822(03)00416-1. Virology. 2003. PMID: 14517087 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

52 results

Search Page